Free Trial

BioSig Technologies (BSGM) Competitors

BioSig Technologies logo
$1.34 +0.04 (+3.08%)
(As of 12/20/2024 05:45 PM ET)

BSGM vs. TELA, GUTS, FONR, MGRM, ECOR, LNSR, EDAP, VANI, NSPR, and HYPR

Should you be buying BioSig Technologies stock or one of its competitors? The main competitors of BioSig Technologies include TELA Bio (TELA), Fractyl Health (GUTS), FONAR (FONR), Monogram Orthopaedics (MGRM), electroCore (ECOR), LENSAR (LNSR), Edap Tms (EDAP), Vivani Medical (VANI), InspireMD (NSPR), and Hyperfine (HYPR). These companies are all part of the "medical equipment" industry.

BioSig Technologies vs.

TELA Bio (NASDAQ:TELA) and BioSig Technologies (NASDAQ:BSGM) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, valuation, dividends, analyst recommendations, risk, media sentiment, profitability, community ranking and earnings.

In the previous week, TELA Bio's average media sentiment score of 0.00 equaled BioSig Technologies'average media sentiment score.

Company Overall Sentiment
TELA Bio Neutral
BioSig Technologies Neutral

TELA Bio has a net margin of -60.49% compared to BioSig Technologies' net margin of -44,832.50%. BioSig Technologies' return on equity of 0.00% beat TELA Bio's return on equity.

Company Net Margins Return on Equity Return on Assets
TELA Bio-60.49% -556.18% -63.13%
BioSig Technologies -44,832.50%N/A -776.49%

BioSig Technologies received 44 more outperform votes than TELA Bio when rated by MarketBeat users. However, 74.68% of users gave TELA Bio an outperform vote while only 70.55% of users gave BioSig Technologies an outperform vote.

CompanyUnderperformOutperform
TELA BioOutperform Votes
59
74.68%
Underperform Votes
20
25.32%
BioSig TechnologiesOutperform Votes
103
70.55%
Underperform Votes
43
29.45%

TELA Bio has a beta of 0.99, suggesting that its share price is 1% less volatile than the S&P 500. Comparatively, BioSig Technologies has a beta of 0.54, suggesting that its share price is 46% less volatile than the S&P 500.

TELA Bio presently has a consensus target price of $9.25, indicating a potential upside of 224.56%. BioSig Technologies has a consensus target price of $2.75, indicating a potential upside of 105.22%. Given TELA Bio's higher probable upside, equities analysts clearly believe TELA Bio is more favorable than BioSig Technologies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
TELA Bio
0 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
3.00
BioSig Technologies
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

94.3% of TELA Bio shares are owned by institutional investors. Comparatively, 7.2% of BioSig Technologies shares are owned by institutional investors. 6.0% of TELA Bio shares are owned by insiders. Comparatively, 17.0% of BioSig Technologies shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

BioSig Technologies has lower revenue, but higher earnings than TELA Bio.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
TELA Bio$68.65M1.64-$46.66M-$1.69-1.69
BioSig Technologies$39K592.18-$29.04MN/AN/A

Summary

TELA Bio beats BioSig Technologies on 8 of the 13 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BSGM vs. The Competition

MetricBioSig TechnologiesElectromedical equipment IndustryMedical SectorNASDAQ Exchange
Market Cap$22.41M$3.07B$5.13B$9.07B
Dividend YieldN/A1.75%5.08%4.23%
P/E RatioN/A17.1689.5817.17
Price / Sales592.1850.221,116.12116.95
Price / CashN/A39.9142.8237.86
Price / Book-4.063.724.774.78
Net Income-$29.04M$89.83M$120.15M$225.60M
7 Day Performance-8.84%-1.76%-1.92%-1.23%
1 Month Performance-30.57%0.32%11.47%3.36%
1 Year Performance-67.32%4.12%30.54%16.60%

BioSig Technologies Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BSGM
BioSig Technologies
1.2184 of 5 stars
$1.34
+3.1%
$2.75
+105.2%
-69.0%$22.41M$39,000.000.0050
TELA
TELA Bio
2.9938 of 5 stars
$2.86
+3.2%
$9.25
+223.4%
-49.8%$112.66M$58.45M-1.64120
GUTS
Fractyl Health
0.8828 of 5 stars
$2.08
+2.0%
$22.00
+957.7%
N/A$100.05M$120,000.00-0.17102
FONR
FONAR
1.0041 of 5 stars
$15.38
-1.0%
N/A-25.8%$97.33M$102.01M11.09480
MGRM
Monogram Orthopaedics
3.2381 of 5 stars
$2.76
+3.8%
$4.00
+44.9%
-24.1%$94.70M$364,999.00-5.6628Gap Down
ECOR
electroCore
2.6011 of 5 stars
$14.15
+4.0%
N/A+164.2%$92.75M$23.33M-7.4450Analyst Forecast
Analyst Revision
News Coverage
LNSR
LENSAR
0.5691 of 5 stars
$7.53
-0.3%
$8.00
+6.2%
+191.7%$87.46M$48.87M-5.17110News Coverage
EDAP
Edap Tms
3.2791 of 5 stars
$2.22
+0.9%
$19.00
+755.9%
-56.2%$82.37M$63.41M-3.38307
VANI
Vivani Medical
2.7875 of 5 stars
$1.31
flat
$3.00
+129.0%
+34.6%$77.60MN/A-2.9120News Coverage
NSPR
InspireMD
2.1967 of 5 stars
$2.97
+0.7%
$4.75
+59.9%
+45.6%$77.47M$6.82M-3.9350Analyst Forecast
Gap Up
HYPR
Hyperfine
2.2929 of 5 stars
$0.97
-3.0%
$1.60
+64.9%
-15.7%$70.76M$13.26M-1.75190

Related Companies and Tools


This page (NASDAQ:BSGM) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners